Periagoge
Scenario

When biotech teams struggle to admit a promising compound isn't working

Our biotech startup team has been dancing around the fact that our lead compound isn't performing as expected and we all see it but no one wants to be the person who says we might need to pivot after eighteen months of work. The investors are asking harder questions and we're running out of ways to stay optimistic without being dishonest.

More people experience this than they realize.

What we've seen

A team's shared investment in hope is preventing them from confronting disappointing data.

Your guide for this
Aurelius
Aurelius works with people navigating exactly this kind of situation.
Ideas that help explain it
Worth thinking about

“Where Are You with Healthcare — Biomedical & Clinical Research?”

Peri

Peri can explain why this happens, help you decide if this is the right situation for you, and point toward the right journey or coach.

If this sounds familiar, the Library can help you find the bigger picture.